We are monitoring the impact of COVID-19 on APAC Ophthalmic Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5303
Share on
Share on

Asia Pacific Ophthalmic Drugs Market Research Report - Segmented By Therapeutic Class, Product Type, Distribution Channel, Disease Indication, Dosage Form, Technology and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 5303
Pages: 145

APAC Ophthalmic Drugs Market Size (2020 to 2025)

As per the research report, the size of the Asia Pacific Ophthalmic Drugs market size is valued at around USD 6.64 billion in 2020. It is expected to grow at a CAGR of 6.9% and worth USD 9.27 billion by 2025. It captures 20% of the global market share.

Ophthalmic drugs are used for the treatment of various eye disorders like cataracts, glaucoma, etc.

An increasing number of people suffering from glaucoma worldwide, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market.

Adverse side-effects and long gestation periods in the development of new drugs hamper market growth.

This research report on the Asia Pacific market has been segmented and sub-segmented into the following categories:

By Therapeutic Class: 

  • Anti-inflammatory Drugs
  • Anti-infective Drugs
  • Anti-glaucoma Drugs
  • Anti-allergy Drugs
  • Anti-VEGF Agents
  • Others

By Product Type: 

  • Prescription Drugs
  • Over-the-Counter Drugs 

By Distribution Channel: 

  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies
  • Drug Stores 

By Disease Indications: 

  • Dry Eye
  • Glaucoma
  • Infection/Inflammation
  • Retinal Disorders
  • Allergy
  • Uveitis
  • Others  

By Dosage Form: 

  • Liquid Ophthalmic Drug Forms
  • Solid Ophthalmic Drug Forms
  • Semisolid Ophthalmic Drug Forms
  • Multicompartment Drug Delivery Systems
  • Other Ophthalmic Drug Forms       

By Technology: 

  • Biologics
  • Cell Therapy
  • Gene Therapy
  • Drug Delivery
  • Small molecule
  • Others 

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific is the fastest growing market and will continue its growth streak till the end of 2025.

Promising companies operating in the Asia-Pacific Ophthalmic Drugs Market profiled in this report are Carl-Zeiss AG, Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.

1. Introduction           

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions                

2. Research Methodology                     

                2.1 Introduction         

                2.2 Research Phases

          2.2.1 Secondary Research           

          2.2.2 Primary Research 

          2.2.3 Econometric Modelling      

          2.2.4 Expert Validation  

                2.3 Analysis Design   

                2.4 Study Timeline    

3. Overview                 

                3.1 Executive Summary                

                3.2 Key Inferences   

                3.3 Epidemology        

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers    

                4.2 Market Restraints                    

                4.3 Key Challenges   

                4.4 Current Opportunities in the Market        

5. Market Segmentation  

                5.1 Therapeutic Class                     

          5.1.1 Introduction           

          5.1.2 Anti-inflammatory Drugs  

    5.1.2.1 Nonsteroidal Anti-inflammatory Drugs

    5.1.2.2 Steroids

          5.1.3 Anti-infective Drugs            

    5.1.3.1 Anti-fungal Drugs

    5.1.3.2 Anti-bacterial Drugs

    5.1.3.3 Others

          5.1.4 Anti-glaucoma Drugs          

    5.1.4.1 Alpha Agonist

    5.1.4.2 Beta Blockers

    5.1.4.3 Prostaglandin Analogs

    5.1.4.4 Combined Medication

    5.1.4.5 Others

          5.1.5 Anti-allergy Drugs

          5.1.6 Anti-VEGF Agents

          5.1.7 Others      

          5.1.8 Y-o-Y Growth Analysis, By Therapeutic Class            

          5.1.9 Market Attractiveness Analysis, By Therapeutic Class          

          5.1.10 Market Share Analysis, By Therapeutic Class         

                5.2 Product Type       

          5.2.1 Introduction           

          5.2.2 Prescription Drugs               

          5.2.3 Over-the-Counter Drugs   

          5.2.4 Y-o-Y Growth Analysis, By Product Type    

          5.2.5 Market Attractiveness Analysis, By Product Type  

          5.2.6 Market Share Analysis, By Product Type    

                5.3 Distribution Channel         

          5.3.1 Introduction           

          5.3.2 Hospital Pharmacies            

          5.3.3 Online  Pharmacies              

          5.3.4 Independent Pharmacies & Drug Stores    

          5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

          5.3.6 Market Attractiveness Analysis, By Distribution Channel    

          5.3.7  Market Share Analysis, By Distribution Channel     

                5.4 Disease Indications                 

          5.4.1 Introduction           

          5.4.2 Dry Eye     

          5.4.3 Glaucoma

          5.4.4 Infection/Inflammation     

          5.4.5 Retinal Disorders  

    5.4.5.1 Wet Age-related Macular Degeneration

    5.4.5.2 Dry Age-related Macular Degeneration

    5.4.5.3 Diabetic Retinopathy

    5.4.5.4 Others

          5.4.6 Allergy      

          5.4.7 Uveitis      

          5.4.8 Others      

          5.4.9 Y-o-Y Growth Analysis, By Disease Indications         

          5.4.10 Market Attractiveness Analysis, By Disease Indications    

          5.4.11 Market Share Analysis, By Disease Indications      

                5.5 Dosage Form       

          5.5.1 Introduction           

          5.5.2 Liquid Ophthalmic Drug Forms        

          5.5.3 Solid Ophthalmic Drug Forms          

          5.5.4 Semisolid Ophthalmic Drug Forms

          5.5.5 Multicompartment Drug Delivery Systems               

          5.5.6 Other Ophthalmic Drug Forms        

          5.5.7 Y-o-Y Growth Analysis, By Dosage Form     

          5.5.8  Market Attractiveness Analysis, By Dosage Form  

          5.5.9  Market Share Analysis, By Dosage Form   

                5.6 Technology                 

          5.6.1 Introduction           

          5.6.2 Biologics   

          5.6.3 Cell Therapy           

          5.6.4 Gene Therapy       

          5.6.5 Drug Delivery         

          5.6.6 Small molecule      

          5.6.7 Others      

          5.6.8 Y-o-Y Growth Analysis, By Technology        

          5.6.9 Market Attractiveness Analysis, By Technology      

          5.6.10 Market Share Analysis, By Technology     

6. Geographical Analysis  

                6.1 Introduction         

          6.1.1 Regional Trends    

          6.1.2 Impact Analysis     

          6.1.3 Y-o-Y Growth Analysis        

    6.1.3.1 By Geographical Area

    6.1.3.2 By Therapeutic Class

    6.1.3.3 By Product Type

    6.1.3.4 By Distribution Channel

    6.1.3.5 By Disease Indication

    6.1.3.6 By Dosage Form

    6.1.3.7 By Technology

          6.1.4  Market Attractiveness Analysis     

    6.1.4.1 By Geographical Area

    6.1.4.2 By Therapeutic Class

    6.1.4.3 By Product Type

    6.1.4.4 By Distribution Channel

    6.1.4.5 By Disease Indication

    6.1.4.6 By Dosage Form

    6.1.4.7 By Technology

          6.1.5  Market Share Analysis      

    6.1.5.1 By Geographical Area

    6.1.5.2 By Therapeutic Class

    6.1.5.3 By Product Type

    6.1.5.4 By Distribution Channel

    6.1.5.5 By Disease Indication

    6.1.5.6 By Dosage Form

    6.1.5.7 By Technology

                6.2 China       

                6.3 India        

                6.4 Japan      

                6.5 South Korea         

                6.6 Australia

7. Strategic Analysis                 

                7.1 PESTLE analysis   

          7.1.1 Political     

          7.1.2 Economic 

          7.1.3 Social         

          7.1.4 Technological         

          7.1.5 Legal          

          7.1.6 Environmental       

                7.2 Porter’s Five analysis        

          7.2.1 Bargaining Power of Suppliers        

          7.2.2 Bargaining Power of Consumers    

          7.2.3 Threat of New Entrants     

          7.2.4 Threat of Substitute Products and Services              

          7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                  

                8.1 Abbott Medical Optics, Inc.                 

          8.1.1 Overview 

          8.1.2 Product Analysis   

          8.1.3 Financial analysis  

          8.1.4 Recent Developments       

          8.1.5 SWOT analysis       

          8.1.6 Analyst View          

                8.2 Carl-Zeiss AG       

                8.3 Ellex Medical Lasers Ltd. 

                8.4 Essilor International S.A. 

                8.5 Hoya Corporation                    

                8.6 Insight Vision Inc.                     

                8.7 Nidek Co.Ltd        

                8.8 Novagali Pharma S A         

                8.9 Topcon Corporation          

                8.10 Ziemer Ophthalmic Systems AG.                    

9. Competitive Landscape                     

                9.1 Market share analysis      

                9.2 Merger and Acquisition Analysis 

                9.3 Agreements, collaborations and Joint Ventures   

                9.4 New Product Launches   

10. Market Outlook and Investment Opportunities                   

Appendix                     

                a) List of Tables                

                b) List of Figures        

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia Pacific Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  2. Asia Pacific Dry Eye Market, By Region, From 2020 to 2025 (USD Billion)
  3. Asia Pacific Glaucoma Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia Pacific Infection/Inflammation Market, By Region, From 2020 to 2025 (USD Billion)
  5. Asia Pacific Retinal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia Pacific Allergy Market, By Region, From 2020 to 2025 (USD Billion)
  7. Asia Pacific Uveitis Market, By Region, From 2020 to 2025 (USD Billion)
  8. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  9. Asia Pacific Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  10. Asia Pacific Anti-inflammatory Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  11. Asia Pacific Anti-infective Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  12. Asia Pacific Anti-glaucoma Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  13. Asia Pacific Anti-allergy Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  14. Asia Pacific Anti-VEGF Agents Market, By Region, From 2020 to 2025 (USD Billion)
  15. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  16. Asia Pacific Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  17. Asia Pacific Prescription Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  18. Asia Pacific Over-the-Counter Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  19. Asia Pacific Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  20. Asia Pacific Hospital Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  21. Asia Pacific Online Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  22. Asia Pacific Independent Pharmacies & Drug Stores Market, By Region, From 2020 to 2025 (USD Billion)
  23. Asia Pacific Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  24. Asia Pacific Liquid Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  25. Asia Pacific Solid Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  26. Asia Pacific Semisolid Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  27. Asia Pacific Multicompartment Drug Delivery Systems Market, By Region, From 2020 to 2025 (USD Billion)
  28. Asia Pacific Other Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  29. Asia Pacific Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  30. Asia Pacific Biologics Market, By Region, From 2020 to 2025 (USD Billion)
  31. Asia Pacific Cell Therapy Market, By Region, From 2020 to 2025 (USD Billion)
  32. Asia Pacific Gene Therapy Market, By Region, From 2020 to 2025 (USD Billion)
  33. Asia Pacific Drug Delivery Market, By Region, From 2020 to 2025 (USD Billion)
  34. Asia Pacific Small molecule Market, By Region, From 2020 to 2025 (USD Billion)
  35. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  36. Japan Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  37. Japan Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  38. Japan Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  39. Japan Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  40. Japan Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  41. Japan Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  42. China Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  43. China Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  44. China Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  45. China Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  46. China Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  47. China Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  48. India Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  49. India Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  50. India Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  51. India Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  52. India Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  53. India Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  54. Australia Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  55. Australia Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  56. Australia Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  57. Australia Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  58. Australia Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  59. Australia Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  60. South Korea Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  61. South Korea Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  62. South Korea Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  63. South Korea Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  64. South Korea Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  65. South Korea Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample